Search

Search Constraints

You searched for: Author/Creator Calvo, E

Search Results

1. 1058PElderly patients with locally advanced head and neck squamous cell carcinoma treated with NBTXR3 nanoparticles activated by radiotherapy: A phase I trial. (23rd October 2018)

3. 1288PSafety and efficacy of anti-PD-1 inhibitor ABBV-181 in lung and head and neck carcinoma. (1st October 2019)

4. 1292PPhase I study of cemiplimab, a human monoclonal anti-PD-1, in patients with unresectable locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC): Longer follow-up efficacy and safety data. (23rd October 2018)

6. 71PPhase I study of cemiplimab, a human monoclonal anti-PD-1, in patients with unresectable locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC): Longer follow-up efficacy and safety data. (17th December 2018)

7. 74PPhase I expansion cohort results of cemiplimab, a human PD-1 monoclonal antibody, in combination with radiotherapy (RT), cyclophosphamide and GM-CSF, in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC). (17th December 2018)